Neuberger High Yield Announces Another 9.05-Cent Payout-18% Yield, Same Discount Warning

Neuberger High Yield Strategies Fund is keeping the payout at 9.05 cents

The fund made the promise back on July 31, when management announced a $0.0905 per share distribution payable on August 31, with both the record date and ex-date set for August 17. That is not a one-off surprise payment. Neuberger High Yield Strategies Fund typically pays 12 dividends per year, and its own distribution policy calls for monthly distributions of the same size. In practice, investors are not buying a growth thesis here; they are buying an income stream, and the key question is whether the portfolio continues to support it.

The income case is straightforward, but the funding question is not

The headline yield is hard to ignore. The fund's Distribution Rate is 18.00995000%, and historical metrics still show an 18.16% dividend yield as of April 23. If the payout stays at 9.05 cents, the fund can remain attractive to investors looking for a large, steady cash flow.

But the market is still signaling caution. NHS currently trades at a -7.94% discount, versus a -2.22% 52-week average discount. The recent $6.50 rights-offering price also offers a benchmark for what fresh capital was willing to pay near NAV. If portfolio income weakens, that 18%-plus yield may reflect market skepticism rather than a free gift.

How the fund tries to keep the payout stable

Portfolio income has to clear several hurdles

Think of this closed-end fund like a rental building with a mortgage. The manager buys a portfolio focused on high-yield debt securities to collect coupons and interest. From there, borrowing costs and fund expenses come out first, and only what remains is available for distribution to investors. If that cash flow softens, a high payout can become harder to sustain.

That is where structure matters. The prospectus says the fund may issue ... shares of common stock and/or transferable subscription rights, giving management another tool if income comes under pressure. And the fund's own declaration says future distributions may consist of net investment income, net realized capital gains and return of capital. In plain English, stability can be preserved for a time, but not at any cost.

Leverage amplifies both income and risk

The funding challenge is not abstract. As of July 30, 2026, the fund reported $408.436M of total investment exposure against $274.155M of common assets, with 32.88% effective leverage. That leverage can boost income when credit markets cooperate, but it also raises the break-even needed to support the payout.

The annual expense profile makes that point clearly enough: 1.18% Interest Expense, 0.82% management Fees, and 1.39% Other Expenses all reduce the cash available for shareholders. Management is also explicit that the ability to maintain the current distribution rate depends on the amount and stability of income received from its investments, the cost of leverage and the level of other Fund fees and expenses.

What matters most for NHS investors

The main debate is simple. Bulls will focus on payout stability and the fund's flexibility to use equity issuances and other tools to keep the check steady. Skeptics will focus on the same mechanics and argue that delaying a cut is not the same as closing an income gap.

For now, the practical watchpoints are clear: - whether portfolio income remains strong enough to underpin the current rate - whether the discount to NAV keeps normalizing or remains depressed - whether management ever needs to lean more heavily on return of capital or fresh equity to maintain the 9.05-cent level